American Diabetes Association ousts chief scientific officer amid ongoing review
Start here
The American Diabetes Association has removed Rita Kalyani, its chief scientific and medical officer, effective immediately, according to a staff notification. The move comes about six weeks after the ADA announced a review of an incident at its June meeting in New Orleans, where armed security escorted out five members who were distributing a Diabetes Care editorial warning of cuts to federal research funding. Kalyani is the second association leader to depart since the episode, and the review that followed it has not yet concluded. Open questions include the review's findings, whether further leadership or policy changes will follow, and how the ADA will address concerns about federal research funding raised in the disputed editorial.
Written by a model from the reports · updated 3 hours ago
Coverage timeline
Follow the coverage to see the different angles.
- STATPickSTAT+: Another diabetes association leader is out while review continues
The American Diabetes Association (ADA) notified this week that Rita Kalyani, its chief scientific and medical officer, is no longer in her role, effective immediately. The change comes about six weeks after the ADA announced a review of the incident at its June New Orleans annual meeting, where five members were escorted out by armed security for distributing a Diabetes Care editorial calling attention to cuts in federal research funding. That review is still ongoing.
Coverage and heat for this story
Reports so far 1·Heat now 9·Peak heat 10 (Oct 22 04:00)·Reports, 24h +1
Two panels, same clock (pointer stays in sync): top is cumulative editorial reports — only rises; last point = All reports; slope = new reports that hour. Bottom is Live-board heatIndex — 7-day participants with a 24-hour half-life, so it can fall when talk cools.